Published “Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial” in The Lancet Oncology — cited 2,318 times.
- #crossref
- #research
- #work